A pretreatment step could help transplanted pancreatic islets survive longer in patients with type 1 diabetes, according to a new preclinical study from Weill Cornell Medicine investigators. One ...
XtalPi has entered a strategic partnership with a biopharmaceutical company to develop oral small-molecule therapeutics targeting a GPCR.
Peer-reviewed preclinical melanoma research finds Provectus’s synthetic small molecule can both stimulate anti-tumor immunity and suppress ...
Immunotherapy has revolutionized cancer treatment, with immune checkpoint inhibitors (ICIs) playing a pivotal role. However, current ICIs, primarily monoclonal antibodies, face significant challenges ...
Hosted on MSN
Discovery about RAF protein in flies 20 years ago leads to phase-1 testing of therapy against solid cancer tumors
Scientists at Université de Montreal and its Institute for Research in Immunology and Cancer have begun a phase-1 clinical trial for a small-molecule therapy for solid tumors. Subscribe to our ...
SOUTH SAN FRANCISCO--(BUSINESS WIRE)--Maze Therapeutics, a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for ...
Rentosertib, an AI-discovered TNIK inhibitor, showed safety and tolerability in a phase 2a trial for idiopathic pulmonary fibrosis. The trial involved 71 patients, with similar adverse event rates ...
MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to ...
The immunofluorescent image shows human islet grafts that were pretreated with three small molecules (and controls for comparison) and transplanted into female or male mice. One week after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results